![Optimizing adherence to allopurinol for gout: patients' perspectives - Spragg - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library Optimizing adherence to allopurinol for gout: patients' perspectives - Spragg - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/c54e6d08-9a25-4434-94bd-8ffebe0fcfa8/bcp15657-fig-0002-m.jpg)
Optimizing adherence to allopurinol for gout: patients' perspectives - Spragg - 2023 - British Journal of Clinical Pharmacology - Wiley Online Library
![Antioxidants | Free Full-Text | Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD Antioxidants | Free Full-Text | Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD](https://www.mdpi.com/antioxidants/antioxidants-11-01297/article_deploy/html/images/antioxidants-11-01297-g001.png)
Antioxidants | Free Full-Text | Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
![Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease | Scientific Reports Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-67026-1/MediaObjects/41598_2020_67026_Fig1_HTML.png)
Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease | Scientific Reports
![Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial - The Lancet Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial - The Lancet](https://www.thelancet.com/cms/attachment/2c5962f0-7ed4-4eb8-8114-559265448c37/gr1.gif)
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial - The Lancet
![Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial - eClinicalMedicine Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial - eClinicalMedicine](https://www.thelancet.com/cms/asset/fa9292b8-b93a-4409-8507-b7eb18a9aa55/gr1.jpg)